Through the budget rectification, CNAS has obtained a significant increase in funds for cost-volume contracts, from 6.2 billion lei to 8.5 billion lei. This amount will allow the continuation of treatments for patients benefiting from innovative therapies and will facilitate access for other patients to essential medications. The president of CNAS, Horațiu-Remus Moldovan, emphasized the importance of this decision for public health and invited pharmaceutical manufacturers to participate in negotiations for new contracts.
Sources
Cum arată rectificarea bugetară pentru Sănătate. Cât primește CNAS de la Guvern pentru medicamente și terapii inovatoare
CNAS a obţinut creşterea plafonului de negociere pentru contractele cost-volum la 8,5 miliarde lei, faţă de 6,2 miliarde lei la începutul anului / Asigură continuitatea tratamentelor pentru peste 450.000 de pacienţi care beneficiază de terapii moderne
Latest News
11:13
Romania is among the countries with the lowest final energy consumption per capita in the EU, according to Eurostat. In 2024, consumption has slightly decreased compared to 2019.
11:07
The number of tourist arrivals decreased by 4.1% in the first six months of 2026, while the number of overnight stays decreased by 6.7%. Germany, Italy, and the USA were the main countries of origin for foreign tourists.
11:03
The Krško nuclear power plant in Slovenia will reduce production to 80% of capacity due to low water levels and high temperatures of the Sava River.
10:55
The Danube reaches a new critical threshold earlier than anticipated. The operations for sinking the barges are resuming.
See more news